Rosivo is a development stage medical device company with patented technologies for transforming animal-derived cartilage into biocompatible cartilage repair implants that feel and function like genuine cartilage, but can resist immune-mediated resorption. Cartesse is a platform technology applicable to many cartilage repair markets. Rhinoplasty is the first target application because of the critical need, large market size, and regulatory path.